| # | Fund | Position value | Shares | Last move | As of |
|---|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | $207.8M | 8.02M | New | Q1 2026 |
| 2 | NEA Management Company, LLC | $191.5M | 7.39M | New | Q1 2026 |
| 3 | Vestal Point Capital, LP | $17.3M | 666.8K | New | Q1 2026 |
| 4 | DEERFIELD MANAGEMENT COMPANY, L.P. | $14.3M | 550.0K | New | Q1 2026 |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | $11.3M | 434.8K | New | Q1 2026 |
| 6 | VANGUARD FIDUCIARY TRUST CO | $1.5M | 59.8K | New | Q1 2026 |
| 7 | Alyeska Investment Group, L.P. | $1.5M | 57.0K | New | Q1 2026 |
| 8 | STATE STREET CORP | $447K | 17.3K | New | Q1 2026 |
| 9 | VANGUARD PORTFOLIO MANAGEMENT LLC | $95K | 3.7K | New | Q1 2026 |
No Form 4 insider transactions on file yet.
| Company | Co-held by | Combined value |
|---|---|---|
| Nuvalent IncNUVL | 5 funds | $2.3B |
| Disc Medicine IncIRON | 5 funds | $360.0M |
| Monopar Therapeutics IncMNPR | 5 funds | $68.2M |
| Boston Scientific CorpBSX | 4 funds | $4.3B |
| Revolution Medicines IncRVMD | 4 funds | $1.1B |
| Rhythm Pharmaceuticals, Inc.RYTM | 4 funds | $780.2M |
| PRAXIS PRECISION MEDICINES IPRAX | 4 funds | $739.0M |
| Arrowhead Pharmaceuticals IncARWR | 4 funds | $678.2M |
| Celcuity Inc.CELC | 4 funds | $638.4M |
| Cogent Biosciences IncCOGT | 4 funds | $623.1M |
| Arcellx, Inc.ACLXGBX | 4 funds | $542.1M |
| Tyra Biosciences IncTYRA | 4 funds | $536.9M |
Ranked by how many of SGP's institutional holders also hold each name — a cross-fund conviction signal. Via the MCP server (ticker.co_held).
No filings captured for this ticker in the live stream yet.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for SGP. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.